文献速递腹部MR

MRI影像组学特征在肝脏与肝细胞癌中的精确性评估

Precision of MRI radiomics features in the liver and hepatocellular carcinoma.
PubMed 文献 · Eur Radiol · 2021-09-26

研究纳入55例患者(含16例未治疗HCC),评估MRI影像组学特征在HCC和肝实质中的重复性、平台间可重复性和观察者间可重复性。结果显示同一MRI系统下重复性可接受,跨平台可重复性差(T1WI形状和一阶特征除外),观察者间可重复性良好。

要点

  • 同一MRI系统下HCC影像组学特征重复性中等至优秀,肝实质中等至良好。
  • 跨MRI平台可重复性差,仅T1WI上HCC的形状和一阶特征较稳定。
  • 观察者间可重复性HCC良好,肝实质可接受。

核心结论

  • MRI影像组学特征在同一MRI系统和不同观察者间具有可接受的重复性,但跨MRI系统可重复性低,仅T1WI上HCC的形状和一阶特征例外。

研究设计与样本

  • 单中心研究纳入55例患者(16例未治疗HCC),行两次增强腹部MRI(间隔1个月内),评估同一系统重测重复性(n=28,10例HCC)、跨平台可重复性(n=27,6例HCC)和观察者间可重复性(n=16,16例HCC)。

诊断标准与关键数值

  • HCC重测重复性:ICC 0.53-0.99,CV 3-29%;肝实质重测重复性:ICC 0.53-0.73,CV 12-19%。
  • 跨平台可重复性:除T1WI上HCC形状和一阶特征(CCC 0.58-0.99,CV 3-15%)外,其余均差。
  • 观察者间可重复性:HCC CCC 0.80-0.99,CV 4-15%;肝实质CCC 0.45-0.86,CV 6-25%。

临床应用与阅片要点

  • 在日常影像组学分析中,应优先使用同一MRI系统采集的数据以减少变异。
  • 跨平台研究需谨慎解读结果,T1WI形状和一阶特征相对稳定可考虑使用。
  • 肝实质影像组学特征稳定性低于HCC,报告时应注明可重复性范围。

局限性

  • 样本量较小(尤其跨平台和观察者间亚组),单中心设计可能限制普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To assess the precision of MRI radiomics features in hepatocellular carcinoma (HCC) tumors and liver parenchyma.

METHODS: The study population consisted of 55 patients, including 16 with untreated HCCs, who underwent two repeat contrast-enhanced abdominal MRI exams within 1 month to evaluate: (1) test-retest repeatability using the same MRI system (n = 28, 10 HCCs); (2) inter-platform reproducibility between different MRI systems (n = 27, 6 HCCs); (3) inter-observer reproducibility (n = 16, 16 HCCs). Shape and 1st- and 2nd-order radiomics features were quantified on pre-contrast T1-weighted imaging (WI), T1WI portal venous phase (pvp), T2WI, and ADC (apparent diffusion coefficient), on liver regions of interest (ROIs) and HCC volumes of interest (VOIs). Precision was assessed by calculating intraclass correlation coefficient (ICC), concordance correlation coefficient (CCC), and coefficient of variation (CV).

RESULTS: There was moderate to excellent test-retest repeatability of shape and 1st- and 2nd-order features for all sequences in HCCs (ICC: 0.53-0.99; CV: 3-29%), and moderate to good test-retest repeatability of 1st- and 2nd-order features for T1WI sequences, and 2nd-order features for T2WI in the liver (ICC: 0.53-0.73; CV: 12-19%). There was poor inter-platform reproducibility for all features and sequences, except for shape and 1st-order features on T1WI in HCCs (CCC: 0.58-0.99; CV: 3-15%). Good to excellent inter-observer reproducibility was found for all features and sequences in HCCs (CCC: 0.80-0.99; CV: 4-15%) and moderate to good for liver (CCC: 0.45-0.86; CV: 6-25%).

CONCLUSIONS: MRI radiomics features have acceptable repeatability in the liver and HCC when using the same MRI system and across readers but have low reproducibility across MR systems, except for shape and 1st-order features on T1WI. Data must be interpreted with caution when performing multiplatform radiomics studies.

KEY POINTS: • MRI radiomics features have acceptable repeatability when using the same MRI system but less reproducible when using different MRI platforms. • MRI radiomics features extracted from T1 weighted-imaging show greater stability across exams than T2 weighted-imaging and ADC. • Inter-observer reproducibility of MRI radiomics features was found to be good in HCC tumors and acceptable in liver parenchyma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Carbonell G, Kennedy P, Bane O, et al. Precision of MRI radiomics features in the liver and hepatocellular carcinoma. Eur Radiol. 2021. PMID: 34564745. doi:10.1007/s00330-021-08282-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。